M A Espinal

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance
    M A Espinal
    Communicable Diseases Cluster, World Health Organization, Geneva, Switzerland
    N Engl J Med 344:1294-303. 2001
  2. ncbi Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey
    M A Espinal
    National Research Center for Maternal and Child Health CENISMI, Santo Domingo, Dominican Republic
    Int J Tuberc Lung Dis 2:490-8. 1998
  3. ncbi Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study
    M A Espinal
    National Centre for Research on Maternal and Child Health, Santo Domingo, Dominican Republic
    Lancet 355:275-80. 2000
  4. ncbi Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries
    M A Espinal
    World Health Organization, Communicable Diseases Programme, Ave Appia 20, 1211 Geneva 27, Switzerland
    JAMA 283:2537-45. 2000
  5. ncbi Determinants of drug-resistant tuberculosis: analysis of 11 countries
    M A Espinal
    World Health Organization, Communicable Diseases, Geneva, Switzerland
    Int J Tuberc Lung Dis 5:887-93. 2001
  6. ncbi Will tuberculosis become resistant to all antibiotics?
    C Dye
    Communicable Diseases, World Health Organization, Geneva, Switzerland
    Proc Biol Sci 268:45-52. 2001
  7. ncbi The burden of drug-resistant tuberculosis and mechanisms for its control
    M C Raviglione
    Communicable Diseases, Stop TB, World Health Organization, Geneva, Switzerland
    Ann N Y Acad Sci 953:88-97. 2001
  8. ncbi Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative
    E Nathanson
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 8:1382-4. 2004

Detail Information

Publications8

  1. ncbi Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance
    M A Espinal
    Communicable Diseases Cluster, World Health Organization, Geneva, Switzerland
    N Engl J Med 344:1294-303. 2001
    ..Data on global trends in resistance to antituberculosis drugs are lacking...
  2. ncbi Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey
    M A Espinal
    National Research Center for Maternal and Child Health CENISMI, Santo Domingo, Dominican Republic
    Int J Tuberc Lung Dis 2:490-8. 1998
    ..The Dominican Republic...
  3. ncbi Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study
    M A Espinal
    National Centre for Research on Maternal and Child Health, Santo Domingo, Dominican Republic
    Lancet 355:275-80. 2000
    ..Thus, we assessed the effect of HIV-1 on the infectiousness of Mycobacterium tuberculosis in a prospective study...
  4. ncbi Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries
    M A Espinal
    World Health Organization, Communicable Diseases Programme, Ave Appia 20, 1211 Geneva 27, Switzerland
    JAMA 283:2537-45. 2000
    ....
  5. ncbi Determinants of drug-resistant tuberculosis: analysis of 11 countries
    M A Espinal
    World Health Organization, Communicable Diseases, Geneva, Switzerland
    Int J Tuberc Lung Dis 5:887-93. 2001
    ..Eleven countries/territories...
  6. ncbi Will tuberculosis become resistant to all antibiotics?
    C Dye
    Communicable Diseases, World Health Organization, Geneva, Switzerland
    Proc Biol Sci 268:45-52. 2001
    ..To substantiate this result, further measurements are needed of the relative fitness of drug-resistant strains...
  7. ncbi The burden of drug-resistant tuberculosis and mechanisms for its control
    M C Raviglione
    Communicable Diseases, Stop TB, World Health Organization, Geneva, Switzerland
    Ann N Y Acad Sci 953:88-97. 2001
    ..The global epidemiology of drug-resistant TB, the impact of standardized short-course chemotherapy (SSC), and the potential future evolution of MDR TB are discussed in this chapter...
  8. ncbi Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative
    E Nathanson
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 8:1382-4. 2004
    ..The study shows that adverse events are manageable in the treatment of MDR-TB in resource-limited settings provided that standard management strategies are applied...